Clinical Trial Update: Transcranial Magnetic Stimulation for Youth With Treatment-Resistant Major Depressive Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial of transcranial magnetic stimulation for youths with treatment-resistant major depressive disorder has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Transcranial Magnetic Stimulation (TMS) device (TMS device)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Major Depressive Disorder | Phase 2 | Status: SUSPENDED